Medicare Enrolled

Dr. Gaurav Sharma, M.D.

Cardiovascular Disease · Rochester, NY
Practice pattern: Cardiac Imaging — Practice with significant diagnostic imaging and stress testing
Low-engagement
1425 PORTLAND AVE, Rochester, NY 14621
5859224193
In practice since 2012 (14 years)
NPI: 1699047068 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sharma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sharma? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sharma

Dr. Gaurav Sharma is a cardiovascular disease specialist in Rochester, NY, with 14 years of NPI registration. Based on federal Medicare data, Dr. Sharma performed 755 Medicare services across 565 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sharma received a total of $5,623 from 28 pharmaceutical and/or device companies across 115 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sharma is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ 755 Medicare services $5,623 industry payments

Medicare Practice Summary

Medicare Utilization ↗
755
Medicare services
Bottom 26% in NY for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
565
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~54 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
129 $72 $291
Regadenoson injection (Lexiscan) for heart stress test
An injection of regadenoson, a medication used to stress the heart during diagnostic testing.
105 $40 $72
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
81 $55 $117
EKG interpretation and report
A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report.
67 $6 $14
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries 64 $301 $375
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
53 $62 $117
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
28 $97 $272
Nuclear stress test with CT scan
A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan.
27 $1,282 $4,655
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review.
27 $53 $122
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
27 $136 $327
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision.
23 $16 $36
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results.
23 $10 $24
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera.
22 $54 $129
Transesophageal echocardiogram
An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function.
19 $82 $199
Echocardiogram, transthoracic
An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers.
19 $14 $30
2-day continuous ECG with professional review
A two-day continuous electrocardiogram recording that includes a review by a healthcare professional.
14 $12 $54
Echocardiogram with color Doppler
An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function.
14 $2 $6
Follow-up heart ultrasound
An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress.
13 $19 $42
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.2% high complexity
36.2% medium
50.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,623
Total received (2018-2024)
Avg $803/year across 7 years
Top 29% in NY for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
115
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,623 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$903
2023
$1,290
2022
$1,906
2021
$602
2020
$437
2019
$240
2018
$244

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$322
AstraZeneca Pharmaceuticals LP
$117
PFIZER INC.
$108
Lilly USA, LLC
$78
Novartis Pharmaceuticals Corporation
$69
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
Impulse Dynamics (USA) Inc.
$28
Lexicon Pharmaceuticals, Inc.
$26
Alnylam Pharmaceuticals Inc.
$24
Inari Medical, Inc.
$18
E.R. Squibb & Sons, L.L.C.
$18
Inspire Medical Systems, Inc.
$17
Regeneron Healthcare Solutions, Inc.
$16
Top 3 companies account for 60.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,180
E.R. Squibb & Sons, L.L.C.
$581
AstraZeneca Pharmaceuticals LP
$428
Boehringer Ingelheim Pharmaceuticals, Inc.
$409
Amarin Pharma Inc.
$281
Novartis Pharmaceuticals Corporation
$277
Alnylam Pharmaceuticals Inc.
$260
Esperion Therapeutics, Inc.
$257
Boston Scientific Corporation
$257
Edwards Lifesciences Corporation
$229
ABIOMED
$205
Novo Nordisk Inc
$199
Lilly USA, LLC
$183
PFIZER INC.
$153
Merck Sharp & Dohme LLC
$128
AngioDynamics, Inc.
$115
Medtronic, Inc.
$110
SCPHARMACEUTICALS INC.
$102
Janssen Pharmaceuticals, Inc
$40
SANOFI-AVENTIS U.S. LLC
$37
Astellas Pharma US Inc
$35
Regeneron Healthcare Solutions, Inc.
$32
Impulse Dynamics (USA) Inc.
$28
Kiniksa Pharmaceuticals, Ltd.
$28
Lexicon Pharmaceuticals, Inc.
$26
Inari Medical, Inc.
$18
Inspire Medical Systems, Inc.
$17
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$7
Top 3 companies account for 38.9% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · AURYON LASER SYSTEM 100-120 VAC · AZURE XT DR MRI SURESCAN · Arcalyst · BRILINTA · CAMZYOS · ELIQUIS · ENTRESTO · EVKEEZA · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · INSPIRE · Impella · JARDIANCE · LEQVIO · LEXISCAN · LifeVest · MOUNJARO · MULTAQ · NEXLETOL · NEXLIZET · ONPATTRO · Optimizer · Ozempic · RESONATE · Repatha · S · VERQUVO · VYNDAMAX · Vascepa · WATCHMAN Access System · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cardiovascular disease specialist in Rochester?
Compare cardiologists in the Rochester area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
92
Per 100K population
12.2
County median income
$74,409
Nearest hospital
ROCHESTER GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sharma is a cardiac imaging specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sharma experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sharma performed 129 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sharma receive payments from pharmaceutical companies?
Yes. Dr. Sharma received a total of $5,623 from 28 companies across 115 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sharma's costs compare to other cardiologists in Rochester?
Dr. Sharma's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sharma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →